1.50Open1.50Pre Close0 Volume10 Open Interest22.50Strike Price0.00Turnover88.23%IV12.20%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier23DDays to Expiry1.50Extrinsic Value100Contract SizeAmericanOptions Type0.4621Delta0.0820Gamma14.26Leverage Ratio-0.0416Theta0.0055Rho6.59Eff Leverage0.0218Vega
PetIQ Stock Discussion
In reaction to earnings/guidance:
• $The Trade Desk(TTD.US)$+17%, $Workiva(WK.US)$ +15.3%, $Arlo Technologies(ARLO.US)$ +12%, $Array Technologies(ARRY.US)$ +10.3%, $Everbridge(EVBG.US)$ +9.7%, $Catalyst Pharmaceuticals(CPRX.US)$ +9.4%, $Halozyme Therapeutics(HALO.US)$ +8.7%, $Velo3D(VLD.US)$ +7.6%, $CyberArk(CYBR.US)$ + 6.2%, $Haemonetics(HAE.US)$ +5.8%, $Jackson Financial(JXN.US)$ +5.7% (also increases dividend), $Axon Enterprise(AXON.US)$ +4.8%, ...
• $Affirm Holdings(AFRM.US)$ +36.4% (also announces multi-year extension of exclusive partnership with SHOP in the US)
• $Robinhood(HOOD.US)$ +22.9% (Emergent Fidelity discloses 7.6% stake; Sam Bankman-Fried CEO of crypto exchange FTX is majority holder in fund)
• $Endeavor Group(EDR.US)$ +20% (in reaction to earnings)
• $Coinbase(COIN.US)$ +13% (in sympathy with HOOD news)
• $Dynavax Technologies(DVAX.US)$ +11.5% (to join ...
• $BLACKSTONE SECD LENDING FD(BXSL.US)$ : Raymond James Upgrades to Outperform from Market Perform - PT $26
• $Constellation Energy(CEG.US)$ : Guggenheim Upgrades to Buy from Neutral - PT $70 (from $51)
• $Copa Holdings(CPA.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $96
• $Krispy Kreme(DNUT.US)$ : HSBC Upgrades to Buy from Hold - PT $17
• $Duolingo(DUOL.US)$ : Raymond James Upgrades to Outperform from Market Perform - PT $98
• $Endeavor Group(EDR.US)$ : Barclay...
• $Intercept Pharmaceuticals(ICPT.US)$ +25.7% (to sell license to commercialize Ocaliva outside the US to Advanz Pharma for upfront payment of $405 mln)
• $Albemarle(ALB.US)$ +13.9% (earnings reports)
• $Booking Holdings(BKNG.US)$ +10% (Booking Holdings' Outlook for a 'Busy' summer season drives the stock sharply higher)
• $AxoGen(AXGN.US)$ +9% (reports top-line results from RECON study of Avance Nerge Graft)
• $Cumulus Media(CMLS.US)$ +7.2% (an...
No comment yet